Wolverine Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-2
Closed -$47 – 2081
2022
Q4
$47 Sell
2
-41
-95% -$1.1K ﹤0.01% 2075
2022
Q3
$1K Sell
43
-11,769
-100% -$413K ﹤0.01% 2323
2022
Q2
$392K Buy
11,812
+9,012
+322% +$383K ﹤0.01% 1046
2022
Q1
$201K Buy
+2,800
New +$202K ﹤0.01% 1166
2021
Q3
– Sell
-1,183
Closed -$172K – 2347
2021
Q2
$196K Buy
1,183
+913
+338% +$148K ﹤0.01% 1271
2021
Q1
$49K Buy
+270
New +$62.6K ﹤0.01% 1638
2020
Q4
– Sell
-561
Closed -$114K – 1867
2020
Q3
$122K Sell
561
-198
-26% -$41.9K ﹤0.01% 1100
2020
Q2
$144K Buy
+759
New +$133K ﹤0.01% 1011
2019
Q3
– Sell
-33,803
Closed -$2.22M – 1618
2019
Q2
$2.24M Buy
+33,803
New +$1.97M 0.03% 406
2018
Q2
– Sell
-5,460
Closed -$267K – 1591
2018
Q1
$220K Buy
+5,460
New +$206K ﹤0.01% 1133

Other funds holding TDOC

Wolverine Asset Management's TDOC Position: Q1 2023 in Review

Wolverine Asset Management sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 2 shares — an estimated $47 sold.

Wolverine Asset Management first reported a position in TDOC in Q1 2018 and held it in 10 quarters. The position peaked at $2.24M in Q2 2019. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Wolverine Asset Management reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Wolverine Asset Management sold 2 Teladoc Health shares in Q1 2023, an estimated $47.
  • Wolverine Asset Management first reported a position in Teladoc Health in Q1 2018 and held it in 10 quarters.
  • Wolverine Asset Management's Teladoc Health position peaked at $2.24M in Q2 2019.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Wolverine Asset Management's 13F filing for Q1 2023, filed 8 May 2023.